Large-scale testing (Phase 3)Study completedNCT02028507
What this trial is testing
Phase III Palbociclib With Endocrine Therapy vs. Capecitabine in HR+/HER2- MBC With Resistance to Aromatase Inhibitors
Who this might be right for
Metastatic Breast Cancer
Spanish Breast Cancer Research Group 693